This strategic alliance is focused on inflammation and neuroscience
The UCB-Oxford Alliance was launched in 2012 with the aim of supporting innovative biomedical research that would help deliver transformative new therapies for patients with high unmet clinical needs. The scientific focus for the Alliance is in immunology and neuroscience and has adopted a collaborative approach to progressing research through joint working and staff exchanges. Together UCB and Oxford Researchers have uncovered a wide range of mutual research interests and the alliance now supports projects across 9 University departments across MSD and MPLS Divisions.
The Alliance’s success is based on common scientific interests and complementary skills and resources. Led by strong leadership from both institutions a joint steering committee helps set a clear long term agenda for the scientific direction of the Alliance, while multi-layered connections throughout the two institutions cement this fruitful relationship.
In addition to the projects supported through the Alliance Oxford and UCB have recently launched a joint Prize Fellowship in Biomedical Research. This scheme will support outstanding researchers in their early scientific career at the University of Oxford. It aims to promote the development of a new generation of exceptional young scientists and clinicians who will become future leaders in their field, while further developing scientific excellence within their field and ultimately improving the lives of patients.
The MSD Business Development team provide ongoing management and support for the alliance. If you would like to find out more about the Alliance or would like an introduction to UCB please contact Oliver Voss in the divisional Business Development Office for further details.